MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, SNDX has $472,668K in assets. $431,046K in debts. $130,893K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
546.77%
Quick Ratio
506.22%
Cash Ratio
151.89%
Debt to Asset Ratio
91.19%
Unit: Thousand (K) dollars
Assets Breakdown
    • Short-term investments
    • Cash and cash equivalents
    • Accounts receivable, net
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Royalty interest financing liabi...
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
130,893 134,930 116,808 108,636
Short-term investments
221,171 259,140 319,171 346,597
Accounts receivable, net
38,116 37,996 25,403 19,454
Inventory, net
-32,754 --
Inventory
34,948 -25,000 17,696
Short-term deposits
9,175 19,616 18,195 13,473
Other receivable, net
267 6,404 0 3,629
Collaboration receivable, net
20,507 23,745 15,736 12,316
Prepaid expenses and other current assets
16,100 13,496 9,517 9,875
Total current assets
471,177 528,081 529,830 531,676
Long-term investments
-0 20,146 62,627
Property and equipment, gross
606 606 --
Accumulated depreciation
429 425 --
Property and equipment, net
177 181 128 0
Right-of-use asset, net
1,212 1,342 1,471 1,629
Restricted cash
102 102 217 217
Total assets
472,668 529,706 551,792 596,149
Accounts payable
10,843 16,580 13,826 17,353
Collaboration payable, net
-0 0 0
Royalty payable
---4,783
Accrued expenses and other current liabilities
74,843 103,064 77,105 71,066
Current portion of royalty interest financing liability
--22,925 19,435
Current portion of royalty interest financing
-0 --
Current portion of right-of-use liability
487 470 329 344
Current portion of capital lease
1 2 2 6
Total current liabilities
86,174 120,116 114,187 112,987
Royalty interest financing, less current portion
-343,909 --
Royalty interest financing liability, less current portion
343,965 -320,985 324,413
Right-of-use liability, less current portion
907 1,051 1,190 1,325
Total long-term liabilities
344,872 344,960 322,175 325,738
Total liabilities
431,046 465,076 436,362 438,725
Common stock, 0.0001 par value, 200,000,000 shares authorized 86,905,343 and 85,694,443 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively
9 9 9 9
Additional paid-in capital
1,590,855 1,570,749 1,553,462 1,534,981
Accumulated other comprehensive gain
11 452 525 285
Accumulated deficit
-1,549,253 -1,506,580 -1,438,566 -1,377,851
Total stockholders equity
41,622 64,630 115,430 157,424
Total liabilities and stockholders equity
472,668 529,706 551,792 596,149
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term investments$221,171K Cash and cashequivalents$130,893K Accounts receivable, net$38,116K Inventory$34,948K Collaboration receivable, net$20,507K Prepaid expenses andother current assets$16,100K Short-term deposits$9,175K Other receivable, net$267K Property and equipment,gross$606K Total current assets$471,177K Right-of-use asset, net$1,212K Property and equipment,net$177K Restricted cash$102K Accumulated depreciation$429K Total assets$472,668K Total liabilities andstockholders equity$472,668K Total liabilities$431,046K Total stockholdersequity$41,622K Accumulated deficit-$1,549,253K Total long-termliabilities$344,872K Total currentliabilities$86,174K Additional paid-in capital$1,590,855K Accumulated othercomprehensive gain$11K Common stock, 0.0001par value,...$9K Royalty interestfinancing liability, less...$343,965K Right-of-use liability, lesscurrent portion$907K Accrued expenses andother current...$74,843K Accounts payable$10,843K Current portion ofright-of-use liability$487K Current portion ofcapital lease$1K

Syndax Pharmaceuticals Inc (SNDX)

Syndax Pharmaceuticals Inc (SNDX)